Rosińska Magdalena
Zakład Epidemiologii Państwowego Zakładu Higieny ul. Chocimska 24, 00-791 Warszawa.
Przegl Epidemiol. 2004;58(1):41-4.
In 2002, 39,978 cases of mumps were reported in Poland. The incidence (104.6 per 100,000) was higher then in 2001 (43.3), which corresponds to a periodical increase of mumps incidence occurring in Poland every 3-4 years. This year's peak is much lower than the previous ones, which can be attributed to the growing vaccine coverage. Even though the mumps vaccine was not included into the national immunization program, the coverage in the 3-year old children reached in 2002 35.5%. Approximately 3.5% of cases were hospitalized (1400) and no mumps deaths were reported. Children 5-9 years old constituted the most affected age group (incidence 965.2 per 100,000). In Poland the MMR vaccine was recommended on voluntary basis in place of measles vaccine for children in their 2nd and 7th year of age. Immunization of 2-years old children is mandatory beginning in 2004.
2002年,波兰报告了39978例腮腺炎病例。发病率(每10万人中104.6例)高于2001年(43.3例),这与波兰每3至4年出现一次的腮腺炎发病率周期性上升情况相符。今年的发病高峰远低于之前的高峰,这可归因于疫苗接种覆盖率的提高。尽管腮腺炎疫苗未被纳入国家免疫规划,但2002年3岁儿童的疫苗接种覆盖率达到了35.5%。约3.5%的病例(1400例)住院治疗,未报告有腮腺炎死亡病例。5至9岁的儿童是受影响最严重的年龄组(发病率为每10万人中965.2例)。在波兰,MMR疫苗是在自愿基础上推荐给2岁和7岁儿童以替代麻疹疫苗的。从2004年起,对2岁儿童进行免疫接种成为强制性要求。